The efficacy of cariprazine in chronic schizophrenia – post hoc analyses of phase II/III clinical trials
Introduction Chronic schizophrenia patients are experiencing persistent and severe illness for more than 15-20 years and are usually suffering from long-term negative symptoms. Cariprazine, a novel D3-D2 partial agonist has been proven to be effective in the treatment of acute schizophrenia, howeve...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cambridge University Press
2022-06-01
|
| シリーズ: | European Psychiatry |
| 主題: | |
| オンライン･アクセス: | https://www.cambridge.org/core/product/identifier/S0924933822008227/type/journal_article |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|